BRD4 PROTAC degrader MZ1 exhibits anti-B-cell acute lymphoblastic leukemia effects via targeting CCND3.
Ma L, Wang J, Yang Y, Lu J, Ling J, Chu X, Zhang Z, Tao Y, Li X, Tian Y, Li Z, Zhang Y, Sang X, Lu L, Wan X, Zhang K, Chen Y, Yu J, Zhuo R, Wu S, Pan J, Zhou X, Hu Y, Hu S.
Ma L, et al. Among authors: yang y.
Hematology. 2023 Dec;28(1):2247253. doi: 10.1080/16078454.2023.2247253.
Hematology. 2023.
PMID: 37594294